NCT06674057

Brief Summary

A randomized control trial will be done on diagnosed stroke patients of subacute stage in Fauji Foundation Hospital Rawalpindi and leading edge physical therapy and rehabilitation clinic.The purpose of the study is to determine Additional Effects of Kinesio-Taping along with conservative Physical Therapy on upper limb function, Range of motion and Spasticity in the patients with Subacute Stroke. The conservational physical therapy includes Passive and active ROMs 25 repetitions each, 3 times per week. PNF stretching (hold relax) for spastic muscles for 20 repetitions with a 10 second hold and 10 second relaxation of the muscle group 3 times per week. D1 flexion and extension for 20 repetitions 3 times per week. Kinesio tape 3 times per week. (Anchor opposed to effected compartment to provide facilitation and sustained stretch). with srtrngth training included in week 3-6 with a resistance band of medium resistance. treatment time will be 30 minutes on alternate days for six weeks.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 20, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 5, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2025

Completed
Last Updated

November 5, 2024

Status Verified

October 1, 2024

Enrollment Period

6 months

First QC Date

November 4, 2024

Last Update Submit

November 4, 2024

Conditions

Keywords

Stroke.subacute strokekinesio tapingproprioceptive neuromuscular facilitationUpper limb function.range of motion

Outcome Measures

Primary Outcomes (2)

  • Spasticity

    velocity dependant passive resistance to stretch will be assesed using the modified ashworth scale.

    6 weeks

  • Upper limb function

    Upper limb function will be assessed using the wolf motor function test for upper limb.

    6 weeks

Secondary Outcomes (1)

  • Range of motion

    6 weeks

Study Arms (2)

experimental group

EXPERIMENTAL

It includes participants receiving kinesio taping in addition to conservational physical therapy for subacute stroke patient's upper limb ROM/spasticity/function. for a period of 6 weeks.

Procedure: KinesioTaping

control group

ACTIVE COMPARATOR

It includes participants receiving conservational physical therapy for subacute stroke patient's upper limb ROM/spasticity/function. for a period of 6 weeks.

Procedure: Control

Interventions

KinesioTapingPROCEDURE

The experimental group will receive the following treatment for week 1-3 (3 days on alternate days): * Passive and active ROMs 25 repetitions each, 3 times per week. * PNF stretching (hold relax) for spastic muscles for 20 repetitions with a 10 second hold and 10 second relaxation of the muscle group 3 times per week. * D1 flexion and extension for 20 repetitions 3 times per week. * Kinesio tape 3 times per week. (Anchor opposed to effected compartment to provide facilitation and sustained stretch). For week 3-6 the treatment will include: * Passive and active ROMs 25 repetitions each, 3 times per week. * PNF stretching (hold relax) for spastic muscles for 20 repetitions with a 10 second hold and 10 second relaxation of the muscle group 3 times per week. * D1 flexion and extension for 20 repetitions 3 times per week. * Strengthening affected muscle groups by resistance training, 3 times per week (using a resistance band of mediu

experimental group
ControlPROCEDURE

The control group will receive the following treatment for week 1-3 on alternate days: * Passive and active ROMs 25 repetitions each, 3 times per week. * PNF stretching (hold relax) for spastic muscles for 20 repetitions with a 10 second hold and 10 second relaxation of the muscle group 3 times per week. * D1 flexion and extension for 20 repetitions 3 times per week. For week 3-6 the treatment will include: * Passive and active ROMs 25 repetitions each, 3 times per week. * PNF stretching (hold relax) for spastic muscles for 20 repetitions with a 10 second hold and 10 second relaxation of the muscle group 3 times per week. * D1 flexion and extension for 20 repetitions 3 times per week. * Strengthening affected muscle groups by resistance training, 3 times per week (using a resistance band of medium resistance).

control group

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age group: 40-65 years onwards
  • Both males and females
  • Patients with history of diagnosed stroke and lie within subacute stage of stroke
  • MAS scale score of 1\_2

You may not qualify if:

  • Any congenital deformities
  • cognitive deficits
  • Fractures
  • Upper limb surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foundation University College of Physical Thrapy

Islamabad, 44000, Pakistan

RECRUITING

MeSH Terms

Conditions

Muscle SpasticityStroke

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

SOHAIB AHMAD, DPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2024

First Posted

November 5, 2024

Study Start

June 20, 2024

Primary Completion

December 20, 2024

Study Completion

January 20, 2025

Last Updated

November 5, 2024

Record last verified: 2024-10

Locations